Advertisement
Research ArticleMinireview

Inhibition of Brain EGFR Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries

Omid Tavassoly, Takashi Sato and Iman Tavassoly
Molecular Pharmacology April 29, 2020, mol.120.119909; DOI: https://doi.org/10.1124/mol.120.119909

Article Information

mol.120.119909
DOI 
https://doi.org/10.1124/mol.120.119909
PubMed 
32350120
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online April 29, 2020.

Article Versions

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Omid Tavassoly1,
  2. Takashi Sato2, and
  3. Iman Tavassoly3,*
  1. 1 Simon Fraser University;
  2. 2 Keio University School of Medicine;
  3. 3 Icahn School of Medicine at Mount Sinai
  1. ↵*Address correspondence to: iman.tavassoly{at}mssm.edu

Statistics from Altmetric.com

Article usage

Article usage: April 2020 to March 2023

AbstractFullPdf
Apr 202094021
May 20203510150
Jun 20203543047
Jul 20201511518
Aug 20201192132
Sep 20201131844
Oct 2020138825
Nov 2020146616
Dec 2020123413
Jan 20211431226
Feb 2021142822
Mar 2021183515
Apr 20212421312
May 2021178514
Jun 20211014760
Jul 20218612534
Aug 2021924138
Sep 2021559149
Oct 2021438672
Nov 2021386957
Dec 2021405643
Jan 2022357174
Feb 2022366043
Mar 2022304449
Apr 2022335255
May 2022407062
Jun 2022345537
Jul 2022324832
Aug 2022295836
Sep 2022366148
Oct 2022295634
Nov 2022368835
Dec 2022204716
Jan 2023195522
Feb 2023216766
Mar 2023259373

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleMinireview

Inhibition of Brain EGFR Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries

Omid Tavassoly, Takashi Sato and Iman Tavassoly
Molecular Pharmacology April 29, 2020, mol.120.119909; DOI: https://doi.org/10.1124/mol.120.119909
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement